Cargando…
Fasting and cancer treatment in humans: A case series report
Short-term fasting (48 hours) was shown to be effective in protecting normal cells and mice but not cancer cells against high dose chemotherapy, termed Differential Stress Resistance (DSR), but the feasibility and effect of fasting in cancer patients undergoing chemotherapy is unknown. Here we descr...
Autores principales: | Safdie, Fernando M., Dorff, Tanya, Quinn, David, Fontana, Luigi, Wei, Min, Lee, Changhan, Cohen, Pinchas, Longo, Valter D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815756/ https://www.ncbi.nlm.nih.gov/pubmed/20157582 |
Ejemplares similares
-
Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy
por: Safdie, Fernando, et al.
Publicado: (2012) -
Safety and feasibility of fasting in combination with platinum-based chemotherapy
por: Dorff, Tanya B., et al.
Publicado: (2016) -
IGF-I regulates the age-dependent signaling peptide humanin
por: Lee, Changhan, et al.
Publicado: (2014) -
Dietary restriction with and without caloric restriction for healthy aging
por: Lee, Changhan, et al.
Publicado: (2016) -
Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection
por: Yu, Steven S, et al.
Publicado: (2016)